Beneficial effects of preoperative lipiodolization for resectable large hepatocellular carcinoma (≥5 cm in diameter)

Journal of Surgical Oncology

Volumn 106, Issue 4, 2012, Pages 498-503

  Yamashita, Yo Ichi ^a,b   Takeishi, Kazuki ^b   Tsuijita, Eiji ^b   Yoshiya, Shouhei ^a   Morita, Kazutoyo ^a   Kayashima, Hiroto ^a   Iguchi, Tomohiro ^a   Taketomi, Akinobu ^a   Shirabe, Ken ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

5 cm in diameter; hepatocellular carcinoma; morbidity and mortality; preoperative lipiodolization; prognosis

Indexed keywords

DOXORUBICIN; EPIRUBICIN; IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MEDICAL RECORD REVIEW; MORBIDITY; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE LIPIODOLIZATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84865122865     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23098     Document Type: Article

References (44)

1. Sheehan R, Hreschchyshyn M, Lin RK, et al.: The use of lymphography as a diagnostic method. Radiology 1961; 76: 47-53.
2. Konno T, Maeda H, Iwai K, et al.: Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium. Cancer 1984; 54: 2367-2374. (Pubitemid 15223375)
3. Kanematsu T, Furuta T, Takenaka K, et al.: A 5-year experience of lipiodolization: Selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10: 98-102. (Pubitemid 19170010)
4. Ogita S, Tokiwa K, Taniguchi H, et al.: Intraarterial chemotherapy with lipid contrast medium for hepatic malignancies in infants. Cancer 1987; 60: 2886-2890. (Pubitemid 18005859)
5. Yamashita Y, Taketomi A, Itoh S, et al.: Phase I/II study of the lipiodolization using DDP-H (CDDP powder; IA-call(«)) in patients with unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 2010; 65: 301-307.
6. Takenaka K, Yoshida K, Nishizaki T, et al.: Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg 1995; 169: 400-404 (discussion 405).
7. Adachi E, Matsumata T, Nishizaki T, et al.: Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 1993; 72: 3593-3598. (Pubitemid 24000592)
8. Makuuchi M, Mori T, Gunvén P, et al.: Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 1987; 164: 155-158. (Pubitemid 17022541)
9. Lanois B:, The intrahepatic Glissonian approach to liver resection. In:, Blumgart LH, Fong Y, Surgery of the liver and Biliary Tract, vol. 2, 3rd edition, London: WB Saunders; 2000. pp. 1698-1703.
10. Takenaka K, Fujiwara Y, Gion T, et al.: A thoracoabdominal hepatectomy and a transdiaphragmatic hepatectomy for patients with cirrhosis and hepatocellular carcinoma. Arch Surg 1998; 133: 80-83. (Pubitemid 28053171)
11. Liu CL, Fan ST, Cheung ST, et al.: Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: A prospective randomized controlled study. Ann Surg 2006; 244: 194-203. (Pubitemid 44305533)
12. Yamashita Y, Hamatsu T, Rikimaru T, et al.: Bile leakage after hepatic resection. Ann Surg 2001; 233: 45-50. (Pubitemid 32042774)
13. Takenaka K, Kawahara N, Yamamoto K, et al.: Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996; 131: 71-76. (Pubitemid 26015411)
14. Shimada M, Takenaka K, Taguchi K, et al.: Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998; 227: 80-85. (Pubitemid 28071341)
15. Shimada M, Takenaka K, Gion T, et al.: Prognosis of recurrent hepatocellular carcinoma: A 10-year surgical experience in Japan. Gastroenterology 1996; 111: 720-726. (Pubitemid 26293238)
16. Imamura H, Matsuyama Y, Miyagawa Y, et al.: Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 1999; 86: 1032-1038. (Pubitemid 29387069)
17. Hasegawa K, Kokudo N, Imamura H, et al.: Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242: 252-259. (Pubitemid 41033442)
18. Yamashita Y, Taketomi A, Itoh S, et al.: Long term favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 Years of experience. J Am Coll Surg 2007; 205: 19-26. (Pubitemid 47016949)
19. Shirabe K, Kanematsu T, Matsumata T, et al.: Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses. Hepatology 1991; 14: 802-805.
20. Fan ST, Ng IO, Poon RT, et al.: Hepatectomy for hepatocellular carcinoma: The surgeon's role in long-term survival. Arch Surg 1999; 134: 1124-1130. (Pubitemid 29473204)
21. Fuster J, Garcia-Valdecasas JC, Grande L, et al.: Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 1996; 223: 297-302. (Pubitemid 26086722)
22. Sasaki A, Iwashita Y, Shibata K, et al.: Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol 2006; 32: 773-779. (Pubitemid 44276006)
23. Zhou WP, Lai EC, Li AJ, et al.: A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009; 249: 195-202.
24. The Liver Cancer Study Group of Japan: The general results for the clinical and pathological study of primary liver cancer, 5th edition. Tokyo: Kanehara Shuppan; 2009.
25. Schwartz JD, Schwartz M, Mandeli J, et al.: Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: Review of the randomised clinical trials. Lancet Oncol 2002; 3: 593-603. (Pubitemid 35174678)
26. Lau WY, Leung TW, Ho SK, et al.: Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial. Lancet 1999; 353: 797-801. (Pubitemid 29110405)
27. Llovet JM, Bruix J:, Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-442. (Pubitemid 36152543)
28. Nagasue N, Galizia G, Kohno H, et al.: Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: A retrospective comparison of 138 liver resections. Surgery 1989; 106: 81-86. (Pubitemid 19186191)
29. Wu CC, Ho YZ, Ho WL, et al.: Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal. Br J Surg 1995; 82: 122-126.
30. Yamasaki S, Hasegawa H, Kinoshita H, et al.: A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 1996; 87: 206-211. (Pubitemid 26099497)
31. Uchida M, Kohno H, Kubota H, et al.: Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg 1996; 20: 326-331. (Pubitemid 26082685)
32. Harada T, Matsuo K, Inoue T, et al.: Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma ? Ann Surg 1996; 224: 4-9. (Pubitemid 26227401)
33. Majno PE, Adam R, Bismuth H, et al.: Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-701.
34. Lu CD, Peng SY, Jiang XC, et al.: Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: Retrospective analysis of 120 cases. World J Surg 1999; 23: 293-300.
35. Zhang Z, Liu Q, He J, et al.: The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000; 89: 2606-2612. (Pubitemid 32011605)
36. Sugo H, Futagawa S, Beppu T, et al.: Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: Relation between postoperative course and the pattern of tumor recurrence. World J Surg 2003; 27: 1295-1299. (Pubitemid 37543023)
37. Choi GH, Kim DH, Kang CM, et al.: Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma ? World J Surg 2007; 31: 2370-2377.
38. Gion T, Taketomi A, Shimada M, et al.: Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma. Hepatology 1998; 28: 1663-1668. (Pubitemid 28549138)
39. Wong IH, Yeo W, Leung T, et al.: Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: A quantitative evaluation. Cancer Lett 2001; 167: 183-191. (Pubitemid 32706682)
40. Shimada M, Hamatsu T, Yamashita Y, et al.: Characteristics of multicentric hepatocellular carcinomas: Comparison with intrahepatic metastasis. World J Surg 2001; 25: 991-995. (Pubitemid 32747645)
41. Shirabe K, Takenaka K, Taketomi A, et al.: Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996; 77: 1050-1055. (Pubitemid 26080893)
42. Adachi E, Maeda T, Matsumata T, et al.: Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995; 108: 768-775.
43. Paye F, Jagot P, Vilgrain V, et al.: Preoperative chemoembolization of hepatocellular carcinoma: A comparative study. Arch Surg 1998; 133: 767-772. (Pubitemid 28324159)
44. Chen XP, Hu DY, Zhang ZW, et al.: Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma. Dig Surg 2007; 24: 208-213.